WHO: Recommendation on use of Hib vaccines in all national immunization programmes

WHO: Recommendation on use of Hib vaccines in all national immunization programmes
In an updated position paper, WHO continues to recommend the inclusion of Haemophilus influenzae type b (Hib) vaccines in all national immunization programmes. Vaccination remains the only effective means of preventing Hib disease and is becoming increasingly important as Hib antibiotic resistance grows. The use of Hib vaccines should be part of a comprehensive strategy to control pneumonia including: exclusive breastfeeding for six months; hand washing with soap; improved water supply and sanitation; reduction of household air pollution; and improved case management at community and health facility levels.

WHO Position Paper on Hib vaccination – September 2013
pdf, 1.27Mb

http://www.who.int/immunization/newsroom/hib_in_national_immunization_programmes/en/index.html

WHO, FAO, OIE Joint Statement: Elimination of human rabies and rabies control in animals

WHO, FAO, OIE Joint Statement: Elimination of human rabies and rabies control in animals
28 September is World Rabies Day. This joint statement promises to eliminate human rabies and control the disease in animals. Rabies kills more than 60 000 people annually, most of them children.
Full details
Read statement
Round table discussion–Rabies
00:14:31 [mp3 13.3Mb]

http://www.who.int/neglected_diseases/en/index.html

CDC/MMWR Watch [to 28 September 2013]

CDC/MMWR Watch [to 28 September 2013]
September 27, 2013 / Vol. 62 / No. 38
:: Influenza Vaccination Coverage Among Health-Care Personnel — United States, 2012–13 Influenza Season
:: Influenza Vaccination Coverage Among Pregnant Women — United States, 2012–13 Influenza Season
:: Updated Information on the Epidemiology of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Infection and Guidance for the Public, Clinicians, and Public Health Authorities, 2012–2013
:: Notes from the Field: Department of Defense Response to a Multistate Outbreak of Fungal Meningitis — United States, October 2012
:: Announcement: Final National and State-Level 2012–13 Influenza Vaccination Coverage Estimates Available Online

Influenza Vaccination Coverage Among Health-Care Personnel — United States, 2012–13 Influenza Season
Weekly http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6238a2.htm?s_cid=mm6238a2_w
September 27, 2013 / 62(38);781-786

Excerpt, Bolded text by Editor
Routine influenza vaccination of health-care personnel (HCP) every influenza season can reduce influenza-related illness and its potentially serious consequences among HCP and their patients (1–5). To protect HCP and their patients, the Advisory Committee on Immunization Practices (ACIP) recommends that all HCP be vaccinated against influenza during each influenza season (5). To estimate influenza vaccination coverage among HCP during the 2012–13 season, CDC conducted an opt-in Internet panel survey of 1,944 self-selected HCP during April 1–16, 2013. This report summarizes the results of that survey, which found that, overall, 72.0% of HCP reported having had an influenza vaccination for the 2012–13 season, an increase from 66.9% vaccination coverage during the 2011–12 season (6). By occupation type, coverage was 92.3% among physicians, 89.1% among pharmacists, 88.5% among nurse practitioners/physician assistants, and 84.8% among nurses. By occupational setting, vaccination coverage was highest among hospital-based HCP (83.1%) and was lowest among HCP at long-term care facilities (LTCF) (58.9%). Vaccination coverage was higher for HCP in occupational settings offering vaccination on-site at no cost for one (75.7%) or multiple (86.2%) days compared with HCP in occupational settings not offering vaccination on-site at no cost (55.3%). Widespread implementation of comprehensive influenza vaccination strategies that focus on improving access to vaccination services is needed to improve HCP vaccination coverage. Influenza vaccination of HCP in all health-care settings might be increased by providing 1) HCP with information on vaccination benefits and risks for themselves and their patients, 2) vaccinations in the workplace at convenient locations and times, and 3) influenza vaccinations at no cost (7,8)…

Report: Ending Poverty in Our Generation: The Next MDG Framework

Report: Ending Poverty in Our Generation: The Next MDG Framework
Save the Children
September 2013
http://www.savethechildren.org/site/c.8rKLIXMGIpI4E/b.8687749/k.CFBF/Post2015.htm

“The world’s current global goals to address extreme poverty – the MDGs – expire in 2015. World leaders have a chance to take this agenda further and finally end extreme poverty in our generation. But it will require more than business as usual – Save the Children’s new report explores how addressing income inequality and improving governance would rapidly accelerate progress.

“A historic achievement is within reach. We can be the generation that ends poverty, forever. For the first time, it is feasible to imagine that in the next couple of decades no child will die from preventable causes, every child will be in school and learning, every child will have protection from violence and we will eradicate absolute poverty.

“The Millennium Development Goals (MDGs), one of the most resonant and unifying agreements in political history, reach a turning point in 2015, the deadline for their realization. We must do everything in our power to achieve them, since they provided an important framework to direct political and financial commitments as well as technical breakthroughs for children. We must also find an agreed way forward on work that will remain to be accomplished.

“As a leading independent organization for children, Save the Children is focused on ensuring that the post-2015 framework clearly accounts for the needs and rights of all children…”

MSF Meeting: The best shot: reaching 22 million missed children – A seminar on accelerating access to vaccination

Meeting: The best shot: reaching 22 million missed children. A seminar on accelerating access to vaccination
MSF
14 October 2013; Oslo, Norway.
“While there have been significant improvements in immunization, more than 1.5 million children die each year of vaccine-preventable diseases. Significant barriers to expanding the reach of vaccines still remain, including the cost of vaccines and the lack of field-adapted products. With more than 22 million children born each year missing their basic immunizations, the international community needs a critical and constructive debate on how to improve universal vaccination coverage.
“The seminar will bring together experienced field practitioners that can share the challenges faced at country level in delivering vaccines with high level policy and decision makers so that we can have a concrete dialogue on what is working and what needs improvement. Speakers include representatives from Médecins Sans Frontières, International Rescue Committee, Duke University, Serum Institute of India, Bill & Melinda Gates Foundation, Harvard University, representatives from country governments, among others.”
Programme and registration: http://www.legerutengrenser.no/Vaart-Arbeid/Vaksineseminar

Viral outbreaks in neonatal intensive care units: What we do not know

American Journal of Infection Control
Vol 41 | No. 10 | October 2013 | Pages 853-948
http://www.ajicjournal.org/current

Viral outbreaks in neonatal intensive care units: What we do not know
Elisa Civardi, MD, Chryssoula Tzialla, MD, Fausto Baldanti, MD, Luisa Strocchio, MD, Paolo Manzoni, MD, Mauro Stronati, MD
http://www.ajicjournal.org/article/S0196-6553%2813%2900189-2/abstract

Abstract
Background
Nosocomial infection is among the most important causes of morbidity, prolonged hospital stay, increased hospital costs, and mortality in neonates, particularly those born preterm. The vast majority of scientific articles dealing with nosocomial infections address bacterial or fungal infections, and viral agents are often disregarded. This analysis reviews the medical literature in an effort to establish the incidence, types of pathogens, and clinical features of noncongenital neonatal viral infections.

Methods
This analysis was performed using the worldwide database of health care–associated outbreaks (http://www.outbreak-database.com). Items analyzed included causative pathogens, types of infection, source of outbreaks, and measures taken to stop outbreaks.

Results
The outbreak database contained a total of 590 neonatal outbreaks, of which 64 were originated by viruses, 44 of which (68.75%) were reported from neonatal intensive care units (NICUs). The 5 most frequent viral agents were rotavirus (23.44%), respiratory syncytial virus (17.19%), enterovirus (15.63%), hepatitis A virus (10.94%), and adenovirus (9.38%).

Conclusion
Our analysis of the viral origins of nosocomial infections in NICUs can be a valuable tool in the investigation of neonatal infections. The mortality rates reported in this analysis demonstrate the significance of noncongenital viral infections in NICUs and the need for more effective outbreak prevention strategies.